Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
interleukin 2 receptor subunit beta | 0.491 | 0.846 | 0.29 |
|
disease | 0.470 | None | 0.909 | 2 | 0 | 1992 | 2019 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.470 | None | 1.000 | 1 | 0 | 2002 | 2014 | ||||||||
|
NFKB inhibitor like 1 | 0.653 | 0.615 | 2.6E-02 |
|
disease | 0.470 | None | 1.000 | 0 | 0 | 2001 | 2011 | ||||||||
|
REL proto-oncogene, NF-kB subunit | 0.579 | 0.692 | 1.00 |
|
disease | 0.460 | None | 0.909 | 3 | 0 | 2009 | 2019 | ||||||||
|
BLK proto-oncogene, Src family tyrosine kinase | 0.585 | 0.769 | 8.3E-14 |
|
disease | 0.460 | None | 1.000 | 2 | 0 | 2009 | 2016 | ||||||||
|
AF4/FMR2 family member 3 | 0.623 | 0.692 | 1.00 |
|
disease | 0.460 | None | 1.000 | 2 | 0 | 2009 | 2016 | ||||||||
|
cyclin dependent kinase 6 | 0.471 | 0.731 | 0.98 |
|
disease | 0.440 | None | 0.714 | 1 | 0 | 2008 | 2019 | ||||||||
|
CD244 molecule | 0.653 | 0.500 | 5.7E-02 |
|
disease | 0.440 | None | 0.500 | 1 | 0 | 2008 | 2011 | ||||||||
|
ankyrin repeat domain 55 | 0.650 | 0.462 | 6.8E-08 |
|
disease | 0.440 | None | 1.000 | 1 | 0 | 2010 | 2019 | ||||||||
|
membrane metalloendopeptidase like 1 | 0.606 | 0.692 | 1.2E-22 |
|
disease | 0.440 | None | 0.909 | 1 | 0 | 2008 | 2019 | ||||||||
|
GATA binding protein 3 | 0.415 | 0.846 | 0.90 |
|
disease | 0.430 | None | 1.000 | 1 | 0 | 2005 | 2019 | ||||||||
|
NFKB inhibitor epsilon | 0.700 | 0.385 | 0.77 |
|
disease | 0.420 | None | 1.000 | 1 | 0 | 2012 | 2016 | ||||||||
|
AT-rich interaction domain 5B | 0.638 | 0.500 | 1.00 |
|
disease | 0.410 | None | 1.000 | 2 | 0 | 2012 | 2019 | ||||||||
|
deoxyribonuclease 1 like 3 | 0.575 | 0.769 | 3.0E-05 |
|
disease | 0.410 | None | 1.000 | 2 | 0 | 2012 | 2019 | ||||||||
|
phospholipase D family member 4 | 0.780 | 0.500 | 7.7E-13 |
|
disease | 0.410 | None | 1.000 | 1 | 0 | 2012 | 2018 | ||||||||
|
kinesin family member 5A | 0.593 | 0.731 | 1.00 |
|
disease | 0.410 | None | 1.000 | 1 | 0 | 2008 | 2014 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
disease | 0.400 | None | 0.976 | 3 | 0 | 1989 | 2020 | ||||||||
|
C-C motif chemokine ligand 21 | 0.502 | 0.769 | 3.6E-02 |
|
disease | 0.400 | None | 0.857 | 3 | 0 | 2003 | 2019 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
disease | 0.400 | None | 0.950 | 2 | 0 | 1995 | 2020 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.400 | None | 0.976 | 2 | 0 | 1988 | 2020 | ||||||||
|
interleukin 1 receptor antagonist | 0.373 | 0.923 | 3.1E-02 |
|
disease | 0.400 | None | 0.947 | 2 | 0 | 1992 | 2020 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.400 | None | 0.952 | 2 | 0 | 1994 | 2019 | ||||||||
|
myeloperoxidase | 0.377 | 0.923 | 7.1E-15 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 2012 | 2020 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
disease | 0.400 | None | 0.968 | 2 | 0 | 1990 | 2020 | ||||||||
|
cytotoxic T-lymphocyte associated protein 4 | 0.369 | 0.923 | 0.94 |
|
disease | 0.400 | None | 0.931 | 2 | 0 | 1998 | 2019 |